There was one negative, the increased revenue did not translate into increased profits.
Slide 14 paints a very interesting picture.
Revenue + 25% - Good
Gross profit +24% - Good
NPATA + 10% - Not Good
There was a lot of leakage in S & M expenses, R & D (Ok with that - it is needed in their business) G & A and finance (understandable due to VIFOR acquisition).
I suspect that there will be some cost reduction occurring very soon in S & M to get Gross profit translating to NAPTA better.
HT1
There was one negative, the increased revenue did not translate...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$276.32 |
Change
0.520(0.19%) |
Mkt cap ! $133.4B | |||
| Open | High | Low | Value | Volume |
| $276.76 | $277.00 | $275.48 | $12.37M | 44.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 43 | $276.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $276.34 | 4 | 1 |
View Market Depth
| Last trade - 10.48am 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$276.03 |
Change
0.520 ( 0.08 %) |
||||
| Open | High | Low | Volume | ||
| $276.39 | $277.00 | $275.45 | 43165 | ||
| Last updated 11.07am 06/05/2024 ? | |||||
| CSL (ASX) Chart |